Cargando…

Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China

Chronic liver disease and liver cancer associated with chronic hepatitis B (CHB) are leading causes of death among adults in China. Although newborn hepatitis B immunization has successfully reduced the prevalence of CHB in children, about 100 million Chinese adults remain chronically infected. If l...

Descripción completa

Detalles Bibliográficos
Autores principales: Toy, Mehlika, Hutton, David W., So, Samuel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633043/
https://www.ncbi.nlm.nih.gov/pubmed/26536626
http://dx.doi.org/10.1371/journal.pone.0139876